BIOS Acquisition Corporation

Leadership & Board of Directors


Jonathan Rigby

Chairman & CBO

Our leadership and board consist of seasoned biotechnology CEOs, senior operators, auditors, investors, and advisors with over 200 years of collective experience. Collectively we have led and advised over 20 IPOs, acquired or divested over 12 companies and generated ~$35 billion in shareholder value via multiple exit strategies including private placements, IPOs, follow-ons, mergers and acquisitions, etc. Our strong track record of raising private and public capital, managing investor relations, together with our deep and current network within the global biotechnology ecosystem differentiates BIOS as an operator-led SPAC.

Ross Haghighat


Professional Career

25+ years of experience as a founder-operator, founder-investor, venture capitalist, and board member

Triton Systems, Inc., Founder, Chairman, and CEO

Jasper Capital Partners, Founding Partner

CITIC Capital Acquisition Corp. (NYSE: CCAC), Director, led recently announced $1.4B business combination with Quanergy

Coretek, Inc., Co-Founder, acquired by Nortel (NYSE: NT) for $1.4 billion

Board Experience

Chinook Therapeutics (NASDAQ: KDNY), Chair of Transaction Committee

Fluence Corporation (ASX: FLC), Chair of Audit Committee

Angel Medical Systems, Lead Director

FRX Polymers, Chairman

Jonathan Rigby

Chairman & CBO

Professional Career

30+ years experience including founder of companies
built on ex-US asset acquisitions

Revolo Biotherapeutics, Board Member, President and Group CEO

United Therapeutics (NASDAQ: UTHR), CEO of SteadyMed Therapeutics (NASDAQ: STDY), a wholly owned subsidiary

SteadyMed Therapeutics Inc.
(NASDAQ: STDY), Founder, President and CEO, acquired by United Therapeutics (NASDAQ: UTHR)

(NASDAQ: ZGNX), Co-Founder, SVP BD


Board Experience

Xeris Pharmaceuticals (NASDAQ: XERS), Director, Chair of Nominating and Governance Committee

CollPlant Biotechnologies (NASDAQ: CLGN), Chairman

ImmunoMolecular Therapeutics

Thermalin Inc

Independent Board of Directors and Advisors

Ronald Eastman

Vice Chairman

Professional Career

EW Healthcare Partners
Senior Advisor


Rinat Neuroscience,
CEO (acquired by Pfizer)

Board Experience

EyePoint Pharmaceuticals

Revance Therapeutics, Inc.



Open Monoclonal Technology

Biotechnology Innovation

    Stephen Sherwin, M.D.


    Professional Career

    Cell Genesys
    Chairman and CEO (merged with BioSante Pharmaceuticals)

    Co-Founder and Chairman (acquired by Sangamo Biosciences)

    Co-Founder and Chairman (acquired by Amgen)

    Third Rock Ventures
    Venture Partner

    Clinical Professor of Medicine

    Zuckerberg San Francisco General Hospital
    Volunteer Attending Physician in Hematology-Oncology

    Board Experience


    Neurocrine Biosciences

    Biotechnology Innovation Organization

      Lou Lange, M.D., Ph.D.


      Professional Career

      CV Therapeutics
      Founder, Chairman, CEO, and Chief Scientific Officer
      (acquired by Gilead for $1.4bn)

      EVP and Senior Advisor

      Asset Management Ventures

      Cardiogen Sciences
      Founder (acquired by Audentes Therapeutics)

      Rapidscan Pharma Solutions
      Founder (acquired by GE Healthcare)

      Executive Chairman and Founder

      Jewish Hospital
      Chief of Cardiology and Professor of Medicine, Washington University School of Medicine

      Board Experience

      (acquired by Astellas for $3.1bn)

      Stealth BioTherapeutics

      Esperion Therapeutics

      Biotechnology Innovation Organization

        Glen Giovannetti


        Professional Career

        Ernst & Young
        Partner, Biotechnology Leader and Global Life Sciences Leader

        Board Experience

        Revolo Biotherapeutics

        Teon Therapeutics

        XWPharma Ltd.

        Biotechnology Innovation Organization

        Life Science Cares

          Shawn Cross


          Professional Career

          Applied Molecular Transport

          JMP Securities
          Managing Director and Co-head of Healthcare Investment Banking

          Deutsche Bank Securities
          Managing Director in Healthcare Investment Banking

          Wells Fargo Securities
          Managing Director and Head of Biopharmaceutical Investment Banking

          GT Biopharma
          Chairman, President, and CEO

          Board Experience

          GT Biopharma